G & PHarma SRL
2.1 FTEThe score of G & PHarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets +3 % Headcount (avg FTE) +24 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
G & PHarma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 12 Jun 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
G & PHarma's financial analysis
- Solvency50.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of G & PHarma
G & PHarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0895.026.720
- VAT number
- BE0895026720
- Peppol
- Registered · 0208:0895026720 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Jan 2008
- Registered office
- 3545 Halen
- Size
- Micro · 2.1 FTE
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
G & PHarma (SRL) has been based in Halen since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 65,161 € and equity of 582,578 €; its revenue is not published. With 2.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 50.3%, above the median of its sector (44.2%).
Companies similar to G & PHarma
Companies in the same business, of comparable size and area, outside its group.
- Stéphanie GEVAERT Activities of holding companies Waregem · balance sheet 801,997 €
- Pharmacie de Rendeux Retail sale of pharmaceutical products Rendeux · balance sheet 867,527 €
- Rutgeerts – Grauwels Management Retail sale of pharmaceutical products Lanaken · balance sheet 858,006 €
- Het Apothekershuis Retail sale of pharmaceutical products Bree · balance sheet €1.78m
- Geassocieerde Apotheek Schilde Retail sale of pharmaceutical products Schilde · balance sheet 637,125 €
- Leuven Pharma Services Retail sale of pharmaceutical products Leuven · balance sheet €2.12m
- Meudon Pharma Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 508,899 €
- Apomertens Retail sale of pharmaceutical products Hulshout · balance sheet €2.97m
Frequently asked questions about G & PHarma
What is the revenue of G & PHarma?
G & PHarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of G & PHarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0895026720 for G & PHarma, if the company is VAT-registered. Its company number (CBE) is 0895.026.720.
Where is the registered office of G & PHarma?
According to the CBE register, the registered office of G & PHarma is in 3545 Halen.
What is the equity of G & PHarma?
At the close of the 2025 financial year, the equity of G & PHarma amounts to 582,578 €, a solvency of 50.3% of total assets.
How many people work at G & PHarma?
2.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages G & PHarma?
The register lists 2 active mandates at G & PHarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of G & PHarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →